Skip to main content

Table 1 Baseline characteristics of study population after propensity-score matching

From: Assessment of effect modification of statins on new-onset diabetes based on various medical backgrounds: a retrospective cohort study

Characteristics Statin users Statin non-users P value
(n = 500) (n = 500)
Age (years, mean ± sd) 60.0 ± 10.9 61.2 ± 13.8 0.1241
Women 281 (56.2) 289 (57.8) 0.6094
Medical history
 Cerebrovascular disease 75 (15.0) 76 (15.2) 0.9296
 Ischemic heart disease 115 (23.0) 102 (20.4) 0.3186
 Other heart disease 112 (22.4) 101 (20.2) 0.3955
 Rheumatoid arthritis 15 (3.0) 18 (3.6) 0.5954
 Liver disease 68 (13.6) 68 (13.6) 1.0000
 Kidney disease 20 (4.0) 25 (5.0) 0.4456
 Hypertension 103 (20.6) 82 (16.4) 0.0872
Medication
 Antihypertensive drugs 216 (43.2) 194 (38.8) 0.1572
  ARB 110 (22.0) 112 (22.4) 0.8790
  ACEI 19 (3.8) 20 (4.0) 0.8702
  Beta blocker 35 (7.0) 33 (6.6) 0.8016
  CCB 124 (24.8) 120 (24.0) 0.7684
  Antihypertensive diuretic 4 (0.8) 2 (0.4) 0.4128
  Other antihypertensive drugs 57 (11.4) 57 (11.4) 1.0000
    Lipid-lowering drugs other than statins
  Fibrate 13 (2.6) 15 (3.0) 0.7014
  Bile acid sequestrant 4 (0.8) 4 (0.8) 1.0000
  Nicotinic acid 7 (1.4) 5 (1.0) 0.5613
  Cholesterol absorption inhibitor 1 (0.2) 0 (0.0) 0.3171
  Other lipid-lowering drugs 16 (3.2) 13 (2.6) 0.5718
 Antithrombotic drug 182 (36.4) 193 (38.6) 0.4724
 Liver disease therapeutic 11 (2.2) 9 (1.8) 0.6514
 Kidney disease therapeutic 4 (0.8) 6 (1.2) 0.5250
 Proton pump inhibitor 92 (18.4) 79 (15.8) 0.2749
 H2 blocker 60 (12.0) 70 (14.0) 0.3471
 NSAID 129 (25.8) 131 (26.2) 0.8854
 Non-thiazide diuretic 35 (7.0) 34 (6.8) 0.9007
 Antiarrhythmic drug 45 (9.0) 46 (9.2) 0.9124
Laboratory parameters
 Triglyceride (mg/dL, mean ± sd) 134.7 ± 65.4 134.4 ± 75.8 0.9494
 Casual glucose (mg/dL, mean ± sd) 102.2 ± 10.0 101.8 ± 10.6 0.6250
  1. Data are numbers of individuals (%) unless otherwise stated. Comparisons of differences in patient characteristics between groups were performed using t-test for continuous variables and chi-squared test for categorical data. Abbreviations: ARB Angiotensin type II receptor blocker, CCB Calcium channel blocker, ACEI Angiotensin-converting enzyme inhibitor, H2 Blocker, histamine2-receptor antagonist, NSAID Non-steroidal anti-inflammatory drug